Advances in Research on Immune Checkpoint Inhibitors-related Enterocolitis and Gut Microbiota / 胃肠病学
Chinese Journal of Gastroenterology
;
(12): 424-427, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-1016352
ABSTRACT
With the application of immune checkpoint inhibitors (ICIs) in the treatment of tumor, the immune-related adverse events often affect the treating process, and the ICI-related enterocolitis is the most common and severe one. Studies on fecal microbiota transplantation revealed that reconstruction of gut microbiota is of great value in the treatment of tumor and other diseases. This article reviewed the advances in research on ICI-related enterocolitis and the role of gut microbiota in tumor immunotherapy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Gastroenterology
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS